(Q36467114)

14 August 2017

CA125 in ovarian tumour tissue at second laparotomy (English)

1 reference

14 August 2017

Maughan TS

1

1 reference

14 August 2017

Fish RG

2

1 reference

14 August 2017

Shelley MD

3

1 reference

14 August 2017

Jasani B

4

1 reference

14 August 2017

Williams GT

5

1 reference

14 August 2017

Adams M

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

59

1 reference

14 August 2017

2

1 reference

14 August 2017

259-260

1 reference

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247003

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247003

CA125 as a serum marker for poor prognosis in ovarian malignancies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247003

Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247003

The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247003

Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types

28 June 2018

1 reference

12 December 2020

Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary

1 reference

12 December 2020

The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy

1 reference

12 December 2020

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

1 reference

12 December 2020

The value of tumour marker CA 125 in surgical pathology

1 reference

12 December 2020

The value of markers in fine tuning of chemotherapy

1 reference

12 December 2020

Evaluation of an immunoradiometric assay for the detection of an ovarian tumour marker, CA125, in serum

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.54

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

2649131

1 reference